DOMAIN THERAPEUTICS

Domain Therapeutics is a biopharmaceutical company located in Strasbourg, France, dedicated to the discovery and early development of small molecules targeting G-coupled Protein Receptors (GPCRs), one of the best classes of drug targets. Domain Therapeutics is using its innovative and proprietary technology platform DTect-Allâ„¢ to identify orthosteric and allosteric ligands of GPCRs, including the so called Silent Allosteric Modulators (SAMs) that represent a unique source of compounds that cannot be discovered by standard technologies. DTect-Allâ„¢ is able to address difficult GPCRs such as orphan and peptidic GPCRs.

#SimilarOrganizations #People #Financial #Website #More

DOMAIN THERAPEUTICS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Pharmaceutical Therapeutics

Founded:

2001-01-01

Address:

Illkirch, Alsace, France

Country:

France

Website Url:

http://www.domaintherapeutics.com

Total Employee:

11+

Status:

Active

Contact:

+33 3 90 40 61 50

Email Addresses:

[email protected]

Total Funding:

89.28 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Domain Not Resolving

Similar Organizations

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

Current Advisors List

sylvie-ryckebusch_image

Sylvie Ryckebusch Board Member @ Domain Therapeutics
Board_member

guillaume-blavier_image

Guillaume Blavier Board Observer @ Domain Therapeutics
Board_observer
2022-05-01

frederic-lemaitre-f-auger_image

Frederic Lemaitre F Auger Board Observer @ Domain Therapeutics
Board_observer
2022-05-01

james-huang_image

James Huang Board Member @ Domain Therapeutics
Board_member
2022-05-01

youssef-bennani_image

Youssef Bennani Chairman of the Board @ Domain Therapeutics
Board_member

bernard-daugeras_image

Bernard Daugeras Board Member @ Domain Therapeutics
Board_member

erwin-boos_image

Erwin Boos Board Observer @ Domain Therapeutics
Board_observer
2022-05-01

katherine-cohen_image

Katherine Cohen Board Observer @ Domain Therapeutics
Board_observer
2022-05-01

Current Employees Featured

pascal-neuville_image

Pascal Neuville
Pascal Neuville Chief Executive Officer @ Domain Therapeutics
Chief Executive Officer

xavier-leroy_image

Xavier Leroy
Xavier Leroy Chief Technology Officer @ Domain Therapeutics
Chief Technology Officer

stanislas-leonard-malmezat_image

Stanislas leonard Malmezat
Stanislas leonard Malmezat Chief Financial Officer @ Domain Therapeutics
Chief Financial Officer

marjorie-sidhoum_image

Marjorie Sidhoum
Marjorie Sidhoum Director of Business Operations @ Domain Therapeutics
Director of Business Operations
2016-01-01

Founder

pascal-neuville_image

Pascal Neuville

Investors List

omnes-capital_image

Investments List

Date	Company	Article	Money raised
2019-09-12	Ermium Therapeutics	Domain Therapeutics investment in Series A - Ermium Therapeutics	6.3 M EUR
2016-10-18	Mavalon Therapeutics	Domain Therapeutics investment in Seed Round - Mavalon Therapeutics	9 M EUR

Official Site Inspections

http://www.domaintherapeutics.com Semrush global rank: 3.76 M Semrush visits lastest month: 3.58 K

Host Informations
Whois Informations

Loading ...